Text Only Version A A A

BPAS comment on today’s ruling regarding the home use of misoprostol in Scotland

Katherine O'Brien, Head of Policy Research at bpas, said:

"bpas welcomes today’s ruling which makes it absolutely clear that the Scottish government’s decision to permit the home use of early abortion medication was legal. Home use is recommended by the World Health Organisation and can spare women the distress of miscarrying on their way home from the clinic. We are pleased that women in Scotland will continue to be offered the choice of taking the medication in their own time and in the privacy of their own home.

"Following this verdict, we are confident that our new Secretary of State for Health will do the right thing by women and bring forward home use in England. This will improve the care we are able to provide to women, and may also reduce the numbers of women seeking abortion pills online, illegally, who risk up to life imprisonment under our archaic abortion law. We look forward to Matt Hancock’s response and to working with the Department of Health to implement home use in England."


For media enquiries please call 0207 061 3377, 07788 725 185 or email press@bpas.org.

Notes to Editors:

About bpas

bpas is a charity which sees more than 70,000 women a year and provides reproductive healthcare services including pregnancy counselling, abortion care, miscarriage management and contraception, at clinics across the UK. It supports and advocates for reproductive choice. More information can be found at bpas.org.